Introduction
The observation of neural cells in the intact brain of a living animal is one of the most significant challenges in neuroscience. Two-photon laser scanning microscopy (TPLSM) enables the cellular imaging of brain tissue up to a depth of several hundred micrometers and the stimulation of a single synapse of neurons by the photolytic release of caged glutamate [1] , and is thus a powerful tool in neuroscience. However, in the case of observing the intact brain of a living animal, one should drill a hole in the skull and remove the dura to observe deep inside the brain tissue and introduce caged glutamate. Thus, bacterial infection and the loss of brain fluid prevent long-term observation over several weeks. Therefore, we have developed an implantable microscale brain interface device for controlling the concentration of chemicals and enabling the long-term observation of cells in the tissues of living animals by applying microfluidic device technology.
Device design and fabrication
The device, which was designed to be implantable into a certain part of the skull to close a drilled hole, is 2.7 mm in diameter and 500 m in thickness, and is expected to enable the delivery of chemicals into the brain tissues and to suppress the pulsatile motion of the brain without the degradation of microscopy observation (Figs. 1(a), (b) and 2). The top plate of the device is made of glass and the bottom part is composed of poly(dimethyl-siloxane) (PDMS) with patterned microchannels. Silicone tubes are connected to the PDMS microchannels. The bottoms of the microchannels are sealed with a newly designed high-strength and biocompatible hydrogel called Tetra-PEG gel [2] to transport chemicals from the microchannels into the brain tissue.
The fabrication procedure of the device is shown in Fig.  1(c) . The microchannels were sealed with Tetra-PEG gel by the binding of Tetra-PEG gel to PDMS with chemical bonds. Tetra-PEG gel was formed by mixing two polymer solutions of tetraamine-terminated PEG (TAPEG) and tetra-NHS-glutarate-terminated PEG (TNPEG). A moderately cross-linked Tetra-PEG gel membrane was formed by micromolding. A thin layer of TAPEG and TNPEG mixed solution was spin-coated as a bonding adhesive layer. Then, APTES-anchored PDMS was placed on the adhesive layer. The TAPEG and TNPEG in the adhesive layer reacted with the amine groups of PDMS and the residual active groups of the Tetra-PEG gel membrane. The amount of residual active groups in the initially formed Tetra-PEG gel was controlled by adjusting the gelation time. E x t e n d e d A b s t r a c t s o f t h e 2 0 1 1 I n t e r n a t i o n a l C o n f e r e n c e o n S o l i d S t a t e D e v i c e s a n d M a t e r i a l s , N a g o y a , 2 0 1 1 , p p 1 1 0 1 -1 1 0 2   H -4 -4 
Experiments
Implantation experiments were performed as follows with all animal care and experimental procedures were carried out in accordance with the regulations of The University of Tokyo. EYFP-expressed transgenic mice were initially anesthetized using a ketamine and xylazine mixture. A 2.7-mm-diameter hole was drilled in the skull directly over the primary visual cortex. The device was inserted into the skull hole and fixed using dental cement. Headgear was attached to the mouse's head to immobilize the mouse on a microscope (Figs. 3(a) and (b) ).
Results and discussion
To observe neural cells in the brain tissues, mice were anesthetized and immobilized under the objective lens of microscope. The brain of a living mouse implanted with the device was observed by TPLSM, and high-resolution (<1 m) microscopy images of neural cells were obtained because the pulsatile motion was successfully suppressed (Figs. 4(a)-(c) ).
To deliver chemicals into the brain tissues through the device, tubes were connected with a syringe. Fluorescent solutions of Alexa594 were injected into the microchannels (100 m width and 200 m height) of the device using a syringe pump. There was no leakage or clogging in the microchannels, because the bonding process of PDMS with Tetra-PEG gel was well controlled. The fluorescent substance was transported from the microchannels into the brain tissue. As shown in Fig. 5 , the diffusive transfer of the delivered fluorescent substance in the brain tissue at depths of 25 m and 50 m was measured by TPLSM.
Although the use of an implantable glass window of 32 mm diameter was previously reported for the long-term imaging of the cortical activity of monkeys [3] , such an approach is not applicable for small animals. Our miniaturized interface device is sufficiently small to be implanted into a mouse and also enables the concentrations of chemicals in the brain tissue to be controlled.
Conclusion
We showed the usefulness of a brain interface device with a permeable hydrogel membrane for controlling the concentration of chemicals and observing cells in the tissues of living animals. Microfluidic device technology has already shown great potential for in vitro biological studies; microfluidic device technology is also expected to be used for in vivo analysis in the field of neuroscience and in the discovery of drugs to treat brain diseases. 
